Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril for Abdominal Radiation Injury
NCT03613506Phase 2Unknown
- Sponsor
- Wuhan University
- Start
- Oct 2019
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of captopril in Acute Radiation Syndrome (ARS), sponsored by Wuhan University. Primary endpoints: Peripheral blood TGF-beta levels at 12 weeks and Protective effect of blocking TGF-beta on normal tissues at 12 weeks. Status: unknown.
02
Drugs
captopril
03
Conditions
Acute Radiation Syndrome (ARS)
Beyond the preview
Go deeper on NCT03613506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03613506.